Targeted ultrasonic contrast agents for molecular imaging and therapy

Gregory M. Lanza, Samuel A. Wickline

Research output: Contribution to journalArticle

134 Scopus citations

Abstract

Targeted contrast agents are expanding the detectability and diagnosis of pathology from a strict anatomic to biochemical basis. Moreover, these new agents, in their various forms, offer the potential for site-specific drug and gene delivery, ie, the "magic bullet" first postulated by Paul Erhlich 100 years ago. The ability to direct drugs to the molecular signatures of disease, to confirm noninvasively their presence at the site-of-interest, and to quantify the adequacy of local drug concentration at the time of treatment, ie, rational targeted drug delivery, offers exciting new clinical paradigms in the near future.

Original languageEnglish
Pages (from-to)13-31
Number of pages19
JournalProgress in cardiovascular diseases
Volume44
Issue number1
DOIs
StatePublished - Jan 1 2001

Fingerprint Dive into the research topics of 'Targeted ultrasonic contrast agents for molecular imaging and therapy'. Together they form a unique fingerprint.

  • Cite this